Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Sacituzumab govitecan
Related studies linked through entity extraction aliases.
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Sacituzumab Govitecan In TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)
- Status
- COMPLETED
- Phase
- PHASE3